NO173767C - Magnetisk resonansbildeforsterkende blanding - Google Patents

Magnetisk resonansbildeforsterkende blanding

Info

Publication number
NO173767C
NO173767C NO873237A NO873237A NO173767C NO 173767 C NO173767 C NO 173767C NO 873237 A NO873237 A NO 873237A NO 873237 A NO873237 A NO 873237A NO 173767 C NO173767 C NO 173767C
Authority
NO
Norway
Prior art keywords
magnetic resonance
paramagnetic
resonance image
image enhancing
atomic number
Prior art date
Application number
NO873237A
Other languages
English (en)
Other versions
NO873237L (no
NO173767B (no
NO873237D0 (no
Inventor
Karl F Kraft
Steven C Quay
Scott M Rocklage
Dilip Worah
Original Assignee
Salutar Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/057,709 external-priority patent/US5039512A/en
Application filed by Salutar Inc filed Critical Salutar Inc
Publication of NO873237D0 publication Critical patent/NO873237D0/no
Publication of NO873237L publication Critical patent/NO873237L/no
Publication of NO173767B publication Critical patent/NO173767B/no
Publication of NO173767C publication Critical patent/NO173767C/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D259/00—Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic System
    • C07F13/005—Compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic System
    • C07F5/003—Compounds containing elements of Groups 3 or 13 of the Periodic System without C-Metal linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/3804—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se) not used, see subgroups
    • C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
    • C07F9/3817—Acids containing the structure (RX)2P(=X)-alk-N...P (X = O, S, Se)
NO873237A 1986-08-04 1987-08-03 Magnetisk resonansbildeforsterkende blanding NO173767C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89313686A 1986-08-04 1986-08-04
US90093086A 1986-08-27 1986-08-27
US07/057,709 US5039512A (en) 1986-08-04 1987-06-15 NMR imaging with paramagnetic polyvalent metal salts of poly-(acid-alkylene-amino)-alkanes

Publications (4)

Publication Number Publication Date
NO873237D0 NO873237D0 (no) 1987-08-03
NO873237L NO873237L (no) 1988-02-05
NO173767B NO173767B (no) 1993-10-25
NO173767C true NO173767C (no) 1994-02-02

Family

ID=27369315

Family Applications (1)

Application Number Title Priority Date Filing Date
NO873237A NO173767C (no) 1986-08-04 1987-08-03 Magnetisk resonansbildeforsterkende blanding

Country Status (16)

Country Link
EP (2) EP0258616B1 (no)
JP (1) JP2667666B2 (no)
AT (1) ATE138809T1 (no)
AU (1) AU608759B2 (no)
CA (1) CA1321346C (no)
DE (2) DE3751829T2 (no)
DK (1) DK167797B1 (no)
ES (2) ES2030023T3 (no)
FI (1) FI88677C (no)
GR (1) GR3004576T3 (no)
HK (1) HK96597A (no)
IE (1) IE64108B1 (no)
IL (2) IL83377A0 (no)
NO (1) NO173767C (no)
NZ (1) NZ221288A (no)
SG (1) SG78250A1 (no)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5064633A (en) * 1984-06-04 1991-11-12 The Dow Chemical Company Macrocyclic aminophosphonic acid complexes, their formulations and use
US5422096A (en) * 1985-05-08 1995-06-06 The General Hospital Corporation Hydroxy-aryl metal chelates for diagnostic NMR imaging
US5250285A (en) * 1985-05-08 1993-10-05 The General Hospital Corporation Hydroxy-aryl metal chelates for diagnostic NMR imaging
WO1989000052A1 (en) * 1987-06-30 1989-01-12 Mallinckrodt, Inc. Method for enhancing the safety of metal-ligand chelates as magnetic resonants imaging agents and x-ray contrast agents
GB8813144D0 (en) * 1988-06-03 1988-07-06 Nycomed As Compositions
GB8900719D0 (en) * 1989-01-13 1989-03-08 Nycomed As Compounds
GB8900732D0 (en) * 1989-01-13 1989-03-08 Nycomed As Agents
GB8916781D0 (en) * 1989-07-21 1989-09-06 Nycomed As Compositions
US5087440A (en) * 1989-07-31 1992-02-11 Salutar, Inc. Heterocyclic derivatives of DTPA used for magnetic resonance imaging
FR2654344B1 (fr) * 1989-11-16 1994-09-23 Cis Bio Int Complexe paramagnetique de gadolinium, son procede de preparation et son utilisation pour le diagnostic par irm.
US5516503A (en) * 1989-11-16 1996-05-14 Guerbet S.A. Diagnostic composition comprising a binuclear complex, its method of preparation and its use in magnetic resonance imaging
CA2069638C (en) * 1989-11-27 1999-02-09 Harry S. Winchell Mri image enhancement of bone and related tissue using complexes of paramagnetic cations and polyphosphonate ligands
US5236695A (en) * 1989-11-27 1993-08-17 Concat, Ltd. MRI image enhancement of bone and related tissue using complexes of paramagnetic cations and polyphosphonate ligands
DE4011684A1 (de) * 1990-04-06 1991-10-10 Schering Ag Dtpa-monoamide, diese verbindungen enthaltende pharmazeutische mittel, ihre verwendung und verfahren zu deren herstellung
US5843399A (en) * 1990-04-06 1998-12-01 Schering Aktiengesellschaft DTPA monoamides for MRI
US5562894A (en) * 1991-08-09 1996-10-08 Regents Of The University Of California Amino-acyl-type and catecholamine-type contrast agents for MRI
IT1252145B (it) * 1991-11-29 1995-06-05 Bracco Ind Chimica Spa Metodo e formulazioni adatte a migliorare lo studio degli organi cavi nell'uomo
DE4302287A1 (de) * 1993-01-25 1994-07-28 Schering Ag Derivatisierte DTPA-Komplexe, diese Verbindungen enthaltende pharmazeutische Mittel, ihre Verwendung und Verfahren zu deren Herstellung
US5409689A (en) * 1993-08-13 1995-04-25 Concat, Ltd. MRI image enhancement using complexes of paramagnetic cations and amine ligands containing a mixture of phosphonate and non-phosphonate pendant arms
US5476644A (en) * 1994-04-13 1995-12-19 Sterling Winthrop Inc. Cyclic triamine chelating agents
US5582814A (en) * 1994-04-15 1996-12-10 Metasyn, Inc. 1-(p-n-butylbenzyl) DTPA for magnetic resonance imaging
US5639746A (en) * 1994-12-29 1997-06-17 The Procter & Gamble Company Hydroxamic acid-containing inhibitors of matrix metalloproteases
TW319763B (no) 1995-02-01 1997-11-11 Epix Medical Inc
JP3356289B2 (ja) * 1995-06-26 2002-12-16 コンキャット リミティド 第一遷移系列元素に対してキレート化親和性および選択性のある化合物とその医療および診断への使用
IT1297035B1 (it) 1997-12-30 1999-08-03 Bracco Spa Derivati dell'acido 1,4,7,10-tetraazaciclododecan-1,4-diacetico
US5980863A (en) * 1998-11-02 1999-11-09 Eagle Vision Pharmaceutical Corporation Manganese compositions and methods for MRI
CA2371728C (en) 1999-06-11 2009-06-02 Neorx Corporation High dose radionuclide complexes for bone marrow suppression
US7094885B2 (en) 1999-07-11 2006-08-22 Neorx Corporation Skeletal-targeted radiation to treat bone-associated pathologies
JP2007062462A (ja) * 2005-08-30 2007-03-15 Nifco Inc 多用途収容装置
US8378134B2 (en) 2009-09-30 2013-02-19 General Electric Company Hydroxylated contrast enhancement agents
NO331773B1 (no) 2009-12-18 2012-03-26 Ge Healthcare As Mangankelater, sammensetninger omfattende slike og anvendelse av disse som kontrastmidler for magnettomografi (MR)
HUE033219T2 (en) 2013-04-26 2017-11-28 Guerbet Sa Contrast medium preparation and related preparation process
GB201610738D0 (en) 2016-06-20 2016-08-03 Ge Healthcare As Chelate compounds
EP3558394B1 (en) 2016-12-21 2020-06-03 GE Healthcare AS Tetraazabicyclo-macrocycle based manganese chelate compounds suitable as mri imaging agents
US11110186B2 (en) 2017-12-20 2021-09-07 General Electric Company Anionic chelate compounds
GB201919073D0 (en) 2019-12-20 2020-02-05 Ge Healthcare As Novel manufacturing process

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3818061A (en) * 1971-11-09 1974-06-18 Merck Sharp & Dohme Transparent nmr shift reagents
DE3129906C3 (de) * 1981-07-24 1996-12-19 Schering Ag Paramagnetische Komplexsalze, deren Herstellung und Mittel zur Verwendung bei der NMR-Diagnostik
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
NL194579C (nl) * 1983-01-21 2002-08-05 Schering Ag Diagnostisch middel.
DE3324235A1 (de) * 1983-07-01 1985-01-10 Schering AG, 1000 Berlin und 4709 Bergkamen Neue komplexbildner, komplexe und komplexsalze
CA1242643A (en) * 1983-08-12 1988-10-04 Eric T. Fossel Nmr imaging utilizing chemical shift reagents
FR2550449B1 (fr) * 1983-08-12 1986-01-31 Commissariat Energie Atomique Agents de relaxation specifiques d'organes ou de pathologies, utilisables pour modifier les contrastes en imagerie medicale par resonance magnetique nucleaire
US4749560A (en) * 1984-08-13 1988-06-07 Research Corporation Metal organo phosphorous compounds for NMR analysis
US4687659A (en) * 1984-11-13 1987-08-18 Salutar, Inc. Diamide-DTPA-paramagnetic contrast agents for MR imaging
US4639365A (en) * 1984-10-18 1987-01-27 The Board Of Regents, The University Of Texas System Gadolinium chelates as NMR contrast agents
GB8518300D0 (en) * 1985-07-19 1985-08-29 Amersham Int Plc Contrast agent
WO1989000052A1 (en) * 1987-06-30 1989-01-12 Mallinckrodt, Inc. Method for enhancing the safety of metal-ligand chelates as magnetic resonants imaging agents and x-ray contrast agents

Also Published As

Publication number Publication date
JP2667666B2 (ja) 1997-10-27
DE3777727D1 (de) 1992-04-30
GR3004576T3 (no) 1993-04-28
ES2087938T3 (es) 1996-08-01
EP0463644A2 (en) 1992-01-02
EP0258616A1 (en) 1988-03-09
HK96597A (en) 1997-08-08
FI88677B (fi) 1993-03-15
EP0258616B1 (en) 1992-03-25
EP0463644A3 (en) 1992-11-19
AU7573587A (en) 1988-02-11
SG78250A1 (en) 2001-02-20
IE64108B1 (en) 1995-07-12
NO873237L (no) 1988-02-05
FI873382A (fi) 1988-02-05
IL83377A0 (en) 1987-12-31
DE3751829T2 (de) 1996-10-31
AU608759B2 (en) 1991-04-18
FI88677C (fi) 1993-06-28
NZ221288A (en) 1990-10-26
EP0463644B1 (en) 1996-06-05
FI873382A0 (fi) 1987-08-04
NO173767B (no) 1993-10-25
DK401087D0 (da) 1987-07-31
JPS63119446A (ja) 1988-05-24
ES2030023T3 (es) 1992-10-16
IL101210A (en) 1996-10-31
ATE138809T1 (de) 1996-06-15
IE872076L (en) 1988-02-04
DK167797B1 (da) 1993-12-20
CA1321346C (en) 1993-08-17
DK401087A (da) 1988-02-05
NO873237D0 (no) 1987-08-03
DE3751829D1 (de) 1996-07-11

Similar Documents

Publication Publication Date Title
NO173767C (no) Magnetisk resonansbildeforsterkende blanding
IL86059A0 (en) Nitrogen-containing cyclic ligands,metallic complexes thereof,diagnostic compositions containing these complexes and the preparation of the ligands
NO306466B1 (no) Blandinger som omfatter tetraazamakrocyklisk forbindelse-metallkomplekser for å forbedre et röntgenbilde, eventuelt en scintigrafiavbildning av et individ, samt tetraazamakrocyklisk forbindelse-metallkomplekser og anvendelse av dem
DE69116637D1 (de) Mittel zur magnetischen Resonanzabbildung
BR9508435A (pt) Quelentes macrocíclicos seus quelatos e usos dos mesmos no campo diagnóstico
EP0230027A3 (en) Magnet shimming using information derived from chemical shift imaging
DE69100842D1 (de) Unlösliche salze von lanthaniden zur bildlichen darstellung des magen-darmtrakts mittels nuklearmagnetischer resonanz.
IT1271043B (it) Chelati paramagnetici per diagnosi in risonanza magnetica nucleare

Legal Events

Date Code Title Description
MK1K Patent expired